Major Probable

説明

Ciprofloxacin and ondansetron both prolong the QT interval; combined use raises the risk of torsades de pointes and sudden cardiac death.

機序

Both agents block hERG (IKr) cardiac potassium channels; additive QTc prolongation results from concurrent administration.

臨床的意義

Fluoroquinolones are a well-established class of QT-prolonging drugs; post-marketing data link the combination to arrhythmia events.

対処法

Avoid when possible; if both are medically necessary, obtain baseline and follow-up ECG and correct electrolyte abnormalities.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.